HDL launches new preventative model to help physicians manage chronic diseases

Health Diagnostic Laboratory Inc. (HDL), www.hdlabinc.com, announced today the launch of its new preventative model to chronic disease management based off a monumental shift in the way physicians test for life threatening conditions.  "The medical community is no longer confined to limited lab results, and is now in a position to more accurately detect the unexpected," said Tonya Mallory, President and CEO, HDL Inc.  "Few moments in medical history have held such promise and opportunity for the prevention of cardiovascular and related chronic diseases while enhancing the continuum of care."

Health Diagnostic Laboratory Inc., headquartered in a new state-of-the-art facility in the Virginia BioTechnology Research Park, offers a comprehensive panel of tests to help physicians personalize treatment based on an expanded, total patient profile.  As a result, HDL Inc. provides more advanced evidence-based treatments, earlier detection of residual risk factors pre-disposing patients to disease and fewer patients progressing to overt disease.

For example, half the people with coronary artery disease have had blood cholesterol levels similar to those of people who have not developed the disease.  As a result, there has been a marked change in the overall scientific understanding of the role of "good" and "bad" cholesterol in metabolic disorders and coronary heart disease (CHD) events. "After 50-plus years of research it is now proven that physicians must measure more in order to understand a patient's overall risks," Mallory said.  

HDL Inc.'s new preventative model approach provides physicians with more advanced tools and scientific evidence to predict angiographic disease or coronary heart disease events.  Positioned as a partner to both the physician and the patient, HDL Inc. moves beyond total cholesterol and outdated measurement techniques, and instead provides physicians with comprehensive and accurate information that surpasses the reach of conventional HDL and LDL analysis.  Physicians therefore can do more than diagnose disease; they can focus on all of the cholesterol components and residual risk factors or biomarkers and their impact on overall heath.  

The founders of HDL Inc., an accredited clinical laboratory, have a rich history of serving at the forefront of renowned medical, educational and industrial institutions.  HDL Inc. uses a comprehensive systems biology approach to eliminate surprises and reverse the alarming increase in chronic disease by providing physicians with:

• access to targeted disease management services for their patients
• improved compliance with treatment plans
• clinical educators to increase patient satisfaction

"HDL Inc. works diligently as a partner with both physician and patient to understand disease and provide support to identify and reverse health risks," said Mallory.  HDL Inc.'s advanced testing options allow physicians to understand their patients' disease on a personal level and to support the individual achievement of health in a way that was never before possible.